查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1837382

外科黏合劑市場按產品類型、配方、應用和最終用戶分類 - 全球預測 2025-2032 年

Surgical Glue Market by Product Type, Formulation, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，外科黏合劑市場規模將達到 132.1 億美元，複合年成長率為 11.21%。

主要市場統計數據
基準年2024年 56.4億美元
預計年份：2025年 62.9億美元
預測年份：2032年 132.1億美元
複合年成長率 (%) 11.21%

權威地闡述了現代外科黏合劑技術、監管變化和臨床需求如何重新定義圍手術全期黏合劑策略。

外科黏合劑的應用範圍已從單純的傷口縫合輔助工具發展成為現代圍手術全期策略的核心多功能工具。臨床醫生現在不僅將這些產品視為止血劑和密封劑，還將其視為實現微創手術、提高手術效率以及減少在精細解剖結構中對縫合線依賴性的關鍵手段。配方技術和給藥系統的進步拓展了其在各個專科的潛在臨床應用，迫使醫院董事會、門診中心和診所重新思考其採購和臨床管道。

同時，法律規範和報銷政策也隨之調整，以反映生技藥品和合成化學品在臨床價值上的差異，並適應新型器械-藥物組合。臨床創新與政策演變的交匯，使得供應商策略和產品開發成為醫療機構決策的重中之重。因此，從臨床領導者到供應鏈經理，相關人員要求更清晰的證據，以證明產品的相對性能、在不同手術環境中的易用性以及與現有工作流程的兼容性。

展望未來，該領域的發展軌跡將取決於製造商如何平衡生物功能與操作實用性。能夠顯著縮短手術時間、降低併發症發生率或實現新型微創手術的創新將影響臨床應用。臨床證據的產生、監管定位和實際應用便利性之間的策略協調將決定哪些產品能夠在外科手術通訊協定中佔據長期偏好。

材料突破、改進的輸送平台以及不斷變化的監管重點如何加速外科黏合劑的普及應用並重新定義標準

外科黏合劑的變化反映了材料科學、遞送工程和臨床實踐三者融合的趨勢，這些趨勢正在重新定義止血和組織縫合的預期。改進的生物黏合劑化學性質使黏合劑的功能超越了簡單的密封，能夠與組織微環境相互作用，在促進癒合的同時最大限度地減少發炎反應。同時，透過客製化劣化曲線和調節合成平台的機械性能，臨床醫生能夠在從血管修復到眼科果凍等各種應用中，使黏合劑的性能與組織的生物力學特性相匹配。

給藥方式的創新同樣重要。單組分、雙組分、即用型混合型以及先進貼片技術的普及，為臨床醫生提供了更多選擇，以應對手術的複雜性和操作限制。氣霧劑和噴射噴霧劑型拓展了黏合劑的效用，使其能夠應用於微創手術等對精準度和用量要求極高的領域。黏合劑的應用範圍曾經僅限於普通外科手術，如今已擴展到心血管、整形外科、牙科和眼科等手術領域，縮短了手術時間，並改善了複雜解剖結構的暴露。

監管機構和支付者正在積極應對，強調具有臨床意義的終點指標，例如減少術後併發症和提高手術效率，而不是僅僅關注基準指標。因此，製造商正優先考慮完善的臨床路徑和真實世界證據的收集。這些技術和系統變革並非漸進式的，而是將催生一種新的護理標準，該標準取決於黏合劑的選擇、與手術流程的整合以及患者獲益的證實。

評估近期關稅變化對外科黏合劑價值鏈供應鏈、採購動態和創新計畫的連鎖反應

針對醫療設備進口徵收關稅將對外科黏合劑生態系統產生複雜且連鎖的影響，尤其是在供應鏈、成本和採購管道方面。關稅將增加依賴跨境生產的零件和成品的到岸成本，促使製造商重新評估籌資策略和供應商合約。為此，許多公司正在加大近岸外包和雙重採購力度，以降低貿易政策波動帶來的風險；而另一些公司則正在加快關鍵合成和配方流程的在地化進程，以保持對醫院採購團隊的價格競爭力。

除了直接的成本影響外，關稅還會使預算有限且報銷週期固定的醫療系統在採購決策方面變得更加複雜。採購主管在評估品牌生物黏合劑與成本更低的合成替代品時，面臨著更艱難的權衡，並且越來越要求進行透明的「總成本護理」分析，該分析應考慮採購價格、手術時間節省、避免併發症以及急性後期資源利用情況。由於關稅會改變與供應商的談判動態，因此，那些擁有靈活的分銷策略並與綜合物流合作夥伴簽訂長期合約的供應商在維持供應的連續性和價格的可預測性方面具有比較優勢。

在營運層面，關稅也會影響創新計畫。考慮對新生產線或配方升級進行資本投資的公司，在建立預期收益和製定定價策略時，必須將關稅導致的成本變化納入考量。這種動態促使研發、製造和商業團隊加快協作，優先考慮那些對供應鏈影響較小或可在國內生產的技術。總而言之，關稅作為一種強制機制，正在再形成整個外科黏合劑產業的供應鏈架構、採購談判和長期投資決策。

透過深入的細分分析，將產品化學成分、配方、臨床用途和最終用戶優先順序與外科手術環境中可操作的推廣管道聯繫起來。

透過精細的細分視角，我們可以發現不同產品類型、配方、臨床應用和終端用戶環境下的效能和應用動態存在差異——每種情況都有其獨特的操作和臨床優先事項。按產品類型分類，生物黏合劑（例如白蛋白和纖維蛋白膠）往往更注重親和性和固有止血活性，因此更適用於易出血或血管豐富的組織；而合成黏合劑（例如氰基丙烯酸酯和聚乙二醇水凝膠）則更注重可預測的機械強度、生產規模的分解性和合理的生產規模化能力。臨床醫生通常會在組織相容性、操作特性和儲存穩定性之間權衡，從而選擇合適的化學成分。

製劑配方差異進一步影響臨床效用。液體製劑包括給藥時混合的雙組分系統和便於操作的單組分製劑。貼片技術提供天然和合成基質，除了黏著性外，還能提供機械支撐。噴霧製劑，無論是氣溶膠還是噴射噴霧，都適用於表面覆蓋和微創操作，在這些情況下，精確定位和均勻分佈至關重要。每種製劑都會影響手術室的工作流程、訓練要求以及與輔助器具（例如施用器和內視鏡端口）的兼容性。

應用趨勢表明，黏合劑的選擇與手術目標密切相關。在心臟瓣膜置換術和血管修復等心血管手術中，黏合劑必須兼顧密封完整性和血液接觸相容性；而在牙科和眼科手術中，微精度和低接觸毒性至關重要。腹部和胸部等普通外科手術需要能夠適應多種組織類型並承受動態機械環境的黏合劑。整形外科應用，例如骨固定和關節修復，則需要具有結構加固潛力並能與固定硬體整合的產品。

終端用戶細分凸顯了不同的採購促進因素。無論是醫院所有還是獨立運作的門診手術中心，都優先考慮快速固化、易於使用且能支援高吞吐量的配方。門診和專科診所則尋求基礎設施要求低、儲存條件明確的黏合劑。公立和私立醫院會從配製流程、臨床委員會核准以及與機構通訊協定的兼容性等方面評估黏合劑。這些細分為產品開發、實證策略和商業化方法提供了依據，使其與臨床實務相契合。

區域對比分析著重闡述了美洲、歐洲、中東和非洲以及亞太地區的動態將如何影響監管互動、採購和臨床應用管道。

區域動態將對外科黏合劑的應用管道、監管互動和分銷策略產生不同的影響。在美洲，先進的醫院系統和門診醫療服務的發展推動了對能夠提高效率和微創手術的黏合劑的需求，而監管機構和報銷機制也越來越傾向於那些能夠減少併發症和提高手術效率的證據。這使得臨床數據、外科醫生培訓計畫和供應鏈可靠性成為商業性成功的關鍵。

監管協調和採購模式多樣化正在歐洲、中東和非洲形成多種不同的應用模式。該地區的高所得市場優先考慮臨床療效和透過既定手術流程實現的互通性，而新興醫療體系則強調成本效益和供應的連續性。製造商必須應對不同的監管管道，並根據當地臨床意見領袖的需求調整溝通策略，同時也要考慮生技藥品的物流和低溫運輸要求。

在亞太地區，醫療基礎設施的異質性以及外科手術能力的快速發展，為優質、具成本效益的黏合劑技術創造了機會。該地區龐大的手術量和對微創手術的投入，有利於可擴展的合成平台和本地化生產合作。同時，監管機構對可靠臨床證據的要求日益提高，促使供應商投資於區域性臨床試驗和上市後監測計畫。這些區域差異影響著全球營運公司的市場進入模式、商業資源分配和臨床證據舉措。

競爭與營運情報重點闡述了產品差異化、主導應用和供應鏈韌性將如何決定外科黏合劑產業的領導地位。

外科黏合劑領域的競爭動態主要集中在產品差異化、實證醫學證據的累積以及透過培訓和穩定的供應來支持臨床應用的能力。領先的創新者傾向於投資轉化研究，將實驗室性能與可驗證的臨床結果聯繫起來，從而向醫院董事會和外科負責人訊息清晰的訊息。那些透過施用器系統、臨床醫生培訓計畫和完善的上市後監測來完善產品系列的公司，能夠更有效地吸引關鍵意見領袖和機構買家的注意。

策略夥伴關係和授權協議在加速產品進入臨床試驗階段和擴大分銷管道方面發揮關鍵作用。利用經銷商網路或與醫療器材製造商合作開發聯合交付平台的公司，通常能夠獲得更廣泛的臨床試驗機會，並在心血管和眼科手術等專科領域更快地被市場接受。此外，那些協調臨床、監管和商業團隊，以產生可操作證據（例如器械對比測試和真實世界性能指標）的機構，往往能夠縮短產品推廣週期。

在製造和供應鏈管理方面表現卓越，能夠幫助企業在相關人員壓力下脫穎而出。那些能夠維持穩定前置作業時間、嚴格遵守品質系統並具備靈活生產能力的企業，更有可能獲得醫院和門診中心的長期合約。此外，企業能否在處方箋和長期供應商名單中保持優先地位，越來越取決於其對使用成本和整體流程影響的關注程度，而不僅僅是採購價格。

為製造商和醫療保健採購領導者提供切實可行的策略指導，以協調創新、供應鏈韌性和商業模式，從而加速臨床應用。

產業領導者應制定一項策略，將研發、監管規劃和商業性執行有機結合，以加速產品推廣應用並降低供應風險。旨在滿足高精度顯微外科手術需求和更廣泛的普通外科手術適應症的產品，將提升產品生命週期價值並簡化培訓流程。此類技術設計應輔以強力的、具有臨床意義的證據計劃，重點關注與採購委員會相關的成果，例如降低併發症和提高工作流程效率。

其次，我們透過地域分散的生產和策略供應商合作來增強供應鏈韌性。將關鍵合成流程外包到近岸地區並尋找多種原料來源，可以降低關稅造成的成本波動和物流中斷風險。同時，投資標準化施用器和培訓模組，可以減少使用者操作技術的差異，並加快臨床醫生認證流程。

第三，商業化策略應與終端使用者的優先事項保持一致。門診手術中心和診所強調易用性、儲存便利性和手術效率。醫院則強調與臨床路徑的整合、配藥流程、長期價值評估。最後，共用結果為導向的商業模式，例如批量採購協議和共享績效指標的試驗計畫，以減少推廣阻力，並創造可衡量的成功案例，從而在整個醫療系統中推廣應用。

採用穩健的混合方法研究途徑，結合臨床醫生訪談、監管指南審查和證據三角驗證，以產出可操作的產業情報。

本研究採用混合方法，將一手質性研究資料與嚴謹的二手檢驗結合，以確保研究結果具有臨床基礎和實際應用價值。一手研究包括對各專科的執業外科醫生、門診中心和醫院的採購負責人以及監管和臨床營運方面的高級專家進行結構化訪談。這些訪談提供了超越實驗室性能數據的背景資訊，重點關注實際應用中的操作特性、配方決策標準以及推動產品應用的臨床終點。

二次檢驗包括對同行評審的臨床文獻、相關監管指南文件和臨床試驗註冊資料進行全面審查，以支援產品性能描述和安全性概況。在適用情況下，也審查了程序指南和共識聲明，以確保產品聲明與臨床最佳實踐相符。資料三角驗證確保從訪談中獲得的經驗性見解得到已發表證據的支持，並符合多個地區觀察到的一致實踐模式。

透過跨職能的同儕評審，確保了分析的嚴謹性，評審人員包括來自臨床、監管和商業領域的專家。採用細分映射法將產品屬性與臨床和最終用戶需求相匹配，並應用敏感度分析來解讀關稅和供應鏈情境。這種調查方法建構了一個情境化的依證，旨在為策略決策提供支持，而無需依賴單一來源的斷言。

對臨床創新、監管預期和供應彈性如何決定長期應用和策略定位進行批判性綜合分析

外科黏合劑正日趨成熟，成為具有戰略意義的臨床工具，其價值不僅限於簡單的止血，還包括最佳化工作流程、提高器械相容性以及改善患者預後。生技藥品和合成化學製劑的改進，以及製劑和遞送方式的創新，為臨床醫生提供了一套全面的套件，以滿足各種手術的機械和生物學需求。同時，採購和監管環境也日益注重結果導向，要求供應商證明其產品在實際應用中的效果和營運效益。

不斷變化的供應鏈現狀和政策凸顯了具有韌性的生產策略和靈活的商業化模式的重要性。那些積極將臨床證據的產生與營運可靠性相結合，並調整其市場推廣策略的企業，將更有利於影響臨床通訊協定的製定，並確保長期的採購承諾。最終，在這個領域取得持久成功需要一種整體性的方法，將科學、臨床效用和切實可行的商業性執行相結合，並以證據為支撐，以持續穩定的供應為保障。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 在門診環境中，氰基丙烯酸酯組織黏合劑的應用日益廣泛，以加速傷口縫合。
  • 利用奈米顆粒技術增強外科黏合劑的抗菌性能
  • 開發可生物分解的止血外科黏合劑以減少術後併發症
  • 紫外光固化外科黏合劑因其在微創手術中實現精確組織黏合而日益受到關注。
  • 製藥公司與醫療設備製造商結成策略聯盟，共同創新外科黏合劑
  • 先進密封劑監管核准的增加將推動新興國家市場擴張。

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章 按產品類型分類的外科黏合劑市場

  • 生物黏合劑
    • 白蛋白
    • 纖維蛋白膠
  • 合成膠黏劑
    • 氰基丙烯酸酯
    • 聚乙二醇水凝膠

9. 按配方分類的外科黏合劑市場

  • 液體
    • 雙組分
    • 一種液體
  • 修補
    • 自然補丁
    • 合成補丁
  • 噴
    • 氣霧劑
    • 噴射

第10章 按應用分類的外科黏合劑市場

  • 心血管外科
    • 心臟瓣膜置換術
    • 血管修復
  • 牙科
  • 一般外科
    • 腹部手術
    • 胸腔外科
  • 眼科手術
  • 整形外科
    • 骨固定
    • 關節修復

第11章 依最終用戶分類的外科黏合劑市場

  • 門診手術中心
    • 醫院所屬的門診手術中心
    • 獨立ASC
  • 診所
    • 門診部
    • 專科診所
  • 醫院
    • 私立醫院
    • 公立醫院

第12章 各地區外科黏合劑市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 外科黏合劑市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國外科黏合劑市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Ethicon, Inc.
    • Medtronic plc
    • B. Braun Melsungen AG
    • 3M Company
    • Baxter International Inc
    • Smith & Nephew plc
    • CryoLife, Inc.
    • Integra LifeSciences Corporation
    • Adhezion Biomedical, LLC
    • Cohera Medical, Inc.
Product Code: MRR-0355054AC4C4

The Surgical Glue Market is projected to grow by USD 13.21 billion at a CAGR of 11.21% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.64 billion
Estimated Year [2025] USD 6.29 billion
Forecast Year [2032] USD 13.21 billion
CAGR (%) 11.21%

An authoritative orientation to how contemporary surgical glue technologies, regulatory shifts, and clinical expectations are redefining perioperative adhesion strategies

The landscape of surgical adhesives has evolved from simple wound closure adjuncts to multifunctional tools central to modern perioperative strategy. Clinicians now view these products not merely as hemostatic or sealing agents but as enablers of minimally invasive approaches, faster throughput, and reduced reliance on sutures in delicate anatomies. Advances in formulation technology and delivery systems have expanded clinical applicability across specialties, prompting hospital committees, ambulatory centers, and clinics to reassess procurement and clinical pathways.

Concurrently, regulatory frameworks and reimbursement considerations have adjusted to reflect the differentiated clinical value of biologic versus synthetic chemistries and to accommodate novel device-drug combination formats. This intersection of clinical innovation and policy evolution places supplier strategy and product development at the forefront of institutional decision-making. As a result, stakeholders from clinical leaders to supply chain managers demand clearer evidence of comparative performance, ease of use in diverse operative environments, and compatibility with existing workflows.

Looking forward, the sector's trajectory will be defined by how manufacturers balance biofunctionality with operational practicality. Innovations that meaningfully reduce procedure time, lower complication rates, or enable new minimally invasive techniques will influence clinical adoption. Strategic alignment between clinical evidence generation, regulatory positioning, and on-the-ground usability will determine which products establish durable preference within surgical protocols.

How materials breakthroughs, refined delivery platforms, and evolving regulatory focus are collectively accelerating adoption and redefining standards for surgical adhesives

The transformation of the surgical adhesive landscape reflects converging forces in materials science, delivery engineering, and clinical practice that collectively redefine expectations for hemostasis and tissue approximation. Improvements in bioadhesive chemistries have enabled adhesives to do more than seal; they now interact with tissue microenvironments to support healing while minimizing inflammatory response. At the same time, synthetic platforms increasingly offer tailored degradation profiles and tunable mechanical properties, allowing clinicians to match adhesive performance with tissue biomechanics in applications ranging from vascular repair to ophthalmic microsurgery.

Delivery innovations have been equally pivotal. The proliferation of single-component liquids, dual-component systems that mix at point of application, and advanced patch technologies provide clinicians with options that align with procedural complexity and access constraints. Aerosol and jet spray modalities extend the utility of adhesives to minimally invasive settings where precision and low-volume application matter. These shifts have also stimulated cross-disciplinary adoption: adhesives once confined to general surgery now feature in cardiovascular, orthopedic, dental, and ophthalmic practices because they can reduce operative time and improve handling in complex anatomies.

Regulatory and payer landscapes have responded by emphasizing clinically meaningful endpoints, such as reduction of postoperative complications and improvements in procedural efficiency, rather than focusing solely on bench metrics. Consequently, manufacturers are prioritizing robust clinical pathways and real-world evidence collection. Taken together, these technological and systemic changes are not incremental; they are enabling new standards of care that hinge on adhesive selection, integration into surgical workflows, and demonstrable patient benefit.

Assessing the ripple effects of recent tariff changes on supply chains, procurement dynamics, and innovation planning across the surgical adhesive value chain

The introduction of tariff measures targeting medical device imports has complex, cascading implications for the surgical adhesives ecosystem, most notably through supply chain, cost, and procurement pathways. Tariffs elevate landed costs for components and finished goods that rely on cross-border manufacturing, prompting manufacturers to reassess sourcing strategies and supplier agreements. In response, many companies intensify nearshoring or dual-sourcing efforts to mitigate exposure to trade policy volatility, while others accelerate localization of critical synthesis and formulation steps to preserve price competitiveness for hospital procurement teams.

Beyond direct cost effects, tariffs complicate purchasing decisions within health systems that operate under constrained budgets and fixed reimbursement schedules. Procurement executives face tougher trade-offs when evaluating branded biologic adhesives versus lower-cost synthetic alternatives, and they increasingly demand transparent total-cost-of-care analyses that account for acquisition price, procedure time savings, complication avoidance, and postacute resource utilization. Because tariffs can shift vendor negotiation dynamics, suppliers that maintain flexible distribution strategies and long-term contracts with integrated logistics partners gain a comparative advantage in sustaining supply continuity and predictable pricing.

Operationally, tariffs also influence innovation planning. Firms contemplating capital investments in new manufacturing lines or formulation upgrades must factor in tariff-induced cost volatility when modeling expected returns and pricing strategies. This dynamic accelerates collaboration between R&D, manufacturing, and commercial teams to prioritize technologies that are less supply-chain sensitive or that can be produced domestically. In sum, tariffs function as a forcing mechanism that reshapes supply chain architecture, procurement negotiations, and long-term investment decisions across the surgical adhesive sector.

Insightful segmentation analysis that maps product chemistries, formulations, clinical applications, and end-user priorities to practical adoption pathways across surgical settings

A granular segmentation lens reveals distinct performance and adoption dynamics across product categories, formulations, clinical applications, and end-user settings, each with its own operational and clinical priorities. Based on product type, biologic adhesives-characterized by albumin and fibrin sealant variants-tend to emphasize biocompatibility and intrinsic hemostatic activity, making them preferred in bleeding-prone or highly vascularized tissues, whereas synthetic adhesives such as cyanoacrylate and polyethylene glycol hydrogel prioritize predictable mechanical strength, controllable degradation, and streamlined manufacturing scalability. Clinicians often choose between these chemistries by weighing tissue compatibility against handling characteristics and storage stability.

Formulation differences further stratify clinical utility. Liquid formats are available as both dual-component systems that mix at the point of delivery and single-component preparations with simplified handling; patch technologies offer natural and synthetic substrates that provide mechanical support in addition to adhesion; and spray delivery, whether aerosol spray or jet spray, caters to surface coverage and minimally invasive access where precise placement and uniform distribution matter. Each formulation influences operating-room workflow, training needs, and device compatibility with adjunctive tools such as applicators or endoscopic ports.

Application-specific trends demonstrate how adhesive choice aligns with surgical objectives. In cardiovascular procedures, including heart valve replacement and vascular repair, adhesives must balance seal integrity with blood-contact compatibility, while in dental and ophthalmic contexts, microprecision and low-contact toxicity are paramount. General surgery applications such as abdominal and thoracic procedures require adhesives that perform across varied tissue types and that tolerate dynamic mechanical environments. Orthopedic indications like bone fixation and joint repair demand products with structural reinforcement potential and integration with fixation hardware.

End-user segmentation underscores divergent procurement drivers. Ambulatory surgical centers, whether hospital owned or independent, prioritize fast-setting, easy-to-use formulations that support high throughput. Clinics, both outpatient and specialty, seek adhesives with minimal infrastructure demands and clear storage profiles. Hospitals, whether private or public, evaluate adhesives through the lenses of formulary processes, clinical committee endorsement, and compatibility with institutional protocols. Together, these segmentation dimensions inform product development, evidence generation strategies, and commercialization approaches tailored to real-world practice.

Comparative regional intelligence revealing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics shape regulatory engagement, procurement, and clinical adoption pathways

Regional dynamics influence adoption pathways, regulatory engagement, and distribution strategies for surgical adhesives in distinct ways. In the Americas, advanced hospital systems and ambulatory care growth drive demand for adhesives that support efficiency gains and minimally invasive procedures, while regulatory agencies and reimbursement mechanisms increasingly favor evidence that demonstrates reductions in complications and improved procedural throughput. This creates a landscape where clinical data, surgeon training programs, and supply chain reliability are central to commercial success.

Across Europe, the Middle East & Africa, regulatory harmonization and varying procurement models produce a mosaic of adoption patterns. High-income markets within this region prioritize clinical outcomes and interoperability with established surgical workflows, whereas emerging healthcare systems emphasize cost-effectiveness and supply continuity. Manufacturers must navigate diverse regulatory pathways and tailor engagement strategies to local clinical opinion leaders, while also considering logistics and cold-chain requirements for biologic chemistries.

In Asia-Pacific, heterogeneous healthcare infrastructures and rapid expansion of surgical capacity create opportunities for both premium and cost-efficient adhesive technologies. The region's large procedural volumes and investment in minimally invasive surgery favor scalable synthetic platforms and localized manufacturing partnerships. At the same time, regulatory agencies increasingly require robust clinical evidence, prompting suppliers to invest in region-specific trials and post-market surveillance initiatives. These regional distinctions shape go-to-market models, allocation of commercial resources, and clinical evidence strategies for firms operating globally.

Competitive and operational intelligence highlighting how product differentiation, evidence-driven adoption, and supply chain resilience determine leadership in the surgical adhesive sector

Competitive dynamics in the surgical adhesive sector center on product differentiation, evidence generation, and the ability to support clinical adoption through training and supply reliability. Leading innovators tend to invest in translational research that connects bench performance with demonstrable clinical outcomes, enabling clearer messaging to hospital committees and surgical leaders. Companies that complement product portfolios with applicator systems, clinician training programs, and robust post-market surveillance create stronger pull through key opinion leaders and institutional buyers.

Strategic partnerships and licensing arrangements play a prominent role in accelerating time-to-clinic and expanding distribution reach. Firms that leverage distributor networks or form alliances with device manufacturers for co-developed delivery platforms often achieve broader trial access and faster uptake in specialty areas such as cardiovascular and ophthalmic surgery. Moreover, organizations that align clinical affairs, regulatory, and commercial teams to generate pragmatic evidence-such as comparative device studies and real-world performance metrics-tend to shorten the adoption curve.

Operational excellence in manufacturing and supply chain management differentiates companies under pressure from procurement stakeholders. Those that demonstrate consistent lead times, quality systems compliance, and flexible production capacity are more likely to be selected for long-term contracts by hospitals and ambulatory centers. Finally, a clear focus on cost-to-use and total procedural impact rather than acquisition price alone increasingly determines which companies sustain preferred status in formularies and long-term supplier lists.

Actionable strategic guidance for manufacturers and healthcare procurement leaders to align innovation, supply resilience, and commercial models for accelerated clinical adoption

Industry leaders should pursue a coordinated strategy that aligns R&D, regulatory planning, and commercial execution to accelerate adoption and mitigate supply risks. First, prioritize development of platform technologies that offer modularity across applications; products designed to serve both high-precision microsurgical needs and broader general surgery indications deliver greater lifecycle value and streamline training. Complement these technical designs with robust, clinically meaningful evidence plans that emphasize outcomes relevant to procurement committees, such as complication reduction and workflow efficiency.

Second, strengthen supply chain resilience through geographically diversified manufacturing and strategic supplier partnerships. Nearshoring critical synthesis steps and qualifying multiple raw-material sources will reduce exposure to tariff-induced cost swings and logistics disruptions. Concurrently, invest in standardized applicators and training modules that reduce variability in user technique and accelerate institutional credentialing, thereby shortening the conversion timeline from trial to formulary inclusion.

Third, tailor commercialization tactics to end-user priorities. For ambulatory surgical centers and outpatient clinics, emphasize ease of use, storage simplicity, and procedural throughput; for hospitals, focus on integration with clinical pathways, formulary processes, and long-term value assessments. Finally, implement outcome-oriented commercial models, such as bundled purchasing agreements or pilot programs with shared performance metrics, to reduce adoption friction and create measurable proof points that can be scaled across health systems.

Robust mixed-methods research approach combining clinician interviews, regulatory guidance review, and evidence triangulation to produce actionable sector intelligence

The research synthesis relies on a mixed-methods approach that integrates primary qualitative inputs with rigorous secondary validation to ensure findings are both clinically grounded and operationally actionable. Primary research included structured interviews with practicing surgeons across specialties, procurement leaders from ambulatory centers and hospitals, and senior regulatory and clinical affairs professionals. These conversations focused on real-world handling characteristics, formulary decision criteria, and clinical endpoints that drive adoption, providing context beyond bench performance data.

Secondary validation encompassed a comprehensive review of peer-reviewed clinical literature, relevant regulatory guidance documents, and clinical trial registries to corroborate performance narratives and safety profiles. Where applicable, procedural guidelines and consensus statements were examined to align product claims with accepted clinical best practices. Data triangulation ensured that anecdotal insights from interviews were supported by published evidence or consistent practice patterns observed across multiple geographies.

Analytical rigor was maintained through cross-functional peer review involving clinical, regulatory, and commercial subject-matter experts. Segmentation mapping was used to align product attributes with clinical and end-user requirements, and sensitivity checks were applied to interpret tariff and supply chain scenarios. This methodology delivered a contextualized evidence base intended to support strategic decision-making without relying on single-source assertions.

Conclusive synthesis of how clinical innovation, regulatory expectations, and supply resilience collectively determine long-term adoption and strategic positioning

Surgical adhesives are maturing into strategic clinical tools whose value extends beyond simple hemostasis to encompass workflow optimization, device compatibility, and patient outcome improvement. The ongoing refinement of biologic and synthetic chemistries, coupled with innovations in formulation and delivery, offers clinicians a broader toolkit tuned to the mechanical and biological requirements of diverse procedures. Meanwhile, procurement and regulatory environments are increasingly outcome-focused, compelling suppliers to demonstrate real-world impact and operational advantages.

Supply chain realities and policy shifts underscore the importance of resilient manufacturing strategies and flexible commercialization models. Organizations that proactively align clinical evidence generation with operational reliability and tailored go-to-market approaches are best positioned to influence clinical protocols and secure long-term procurement commitments. In conclusion, durable success in this sector requires a holistic approach that integrates science, clinical utility, and pragmatic commercial execution-anchored by evidence and reinforced by supply continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of cyanoacrylate-based tissue adhesives for faster wound closure in outpatient settings
  • 5.2. Technological integration of nanoparticles to enhance antimicrobial properties in surgical glues
  • 5.3. Development of biodegradable and hemostatic surgical adhesives to reduce post-surgical complications
  • 5.4. Growing focus on UV-curable surgical glues for precise tissue bonding in minimally invasive procedures
  • 5.5. Strategic partnerships between pharmaceutical companies and medical device manufacturers to innovate surgical adhesives
  • 5.6. Increasing regulatory approvals for advanced sealants driving market expansion in emerging economies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Glue Market, by Product Type

  • 8.1. Biological Adhesive
    • 8.1.1. Albumin
    • 8.1.2. Fibrin Sealant
  • 8.2. Synthetic Adhesive
    • 8.2.1. Cyanoacrylate
    • 8.2.2. Polyethylene Glycol Hydrogel

9. Surgical Glue Market, by Formulation

  • 9.1. Liquid
    • 9.1.1. Dual Component
    • 9.1.2. Single Component
  • 9.2. Patch
    • 9.2.1. Natural Patch
    • 9.2.2. Synthetic Patch
  • 9.3. Spray
    • 9.3.1. Aerosol Spray
    • 9.3.2. Jet Spray

10. Surgical Glue Market, by Application

  • 10.1. Cardiovascular Surgery
    • 10.1.1. Heart Valve Replacement
    • 10.1.2. Vascular Repair
  • 10.2. Dental
  • 10.3. General Surgery
    • 10.3.1. Abdominal Procedures
    • 10.3.2. Thoracic Procedures
  • 10.4. Ophthalmic Surgery
  • 10.5. Orthopedic Surgery
    • 10.5.1. Bone Fixation
    • 10.5.2. Joint Repair

11. Surgical Glue Market, by End User

  • 11.1. Ambulatory Surgical Center
    • 11.1.1. Hospital Owned ASC
    • 11.1.2. Independent ASC
  • 11.2. Clinic
    • 11.2.1. Outpatient Clinic
    • 11.2.2. Specialty Clinic
  • 11.3. Hospital
    • 11.3.1. Private Hospital
    • 11.3.2. Public Hospital

12. Surgical Glue Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Surgical Glue Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Surgical Glue Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Ethicon, Inc.
    • 15.3.2. Medtronic plc
    • 15.3.3. B. Braun Melsungen AG
    • 15.3.4. 3M Company
    • 15.3.5. Baxter International Inc
    • 15.3.6. Smith & Nephew plc
    • 15.3.7. CryoLife, Inc.
    • 15.3.8. Integra LifeSciences Corporation
    • 15.3.9. Adhezion Biomedical, LLC
    • 15.3.10. Cohera Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL GLUE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SURGICAL GLUE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL GLUE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL SURGICAL GLUE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. SURGICAL GLUE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. SURGICAL GLUE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SURGICAL GLUE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL GLUE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL GLUE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SURGICAL GLUE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL GLUE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS SURGICAL GLUE MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS SURGICAL GLUE MARKET SIZE, BY PATCH, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS SURGICAL GLUE MARKET SIZE, BY SPRAY, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS SURGICAL GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS SURGICAL GLUE MARKET SIZE, BY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 332. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 333. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 334. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 335. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 336. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 337. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 338. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 339. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
  • TABLE 340. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2025-2032 (USD MILLION)
  • TABLE 341. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 342. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 343. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 344. EUROPE, MIDDLE E